Bariatrics and endoscopic therapies for the treatment of metabolic disease: Past, present, and future
{{output}}
The burden of chronic metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and metabolic dysfunction-associated steatotic liver disease (MASLD) and the urgency of the epidemiological situation necessitate the development of therapies that enhan... ...
